NOVUS THERAPEUTICS, INC. Chart calendar Novus Therapeutics, Inc.
e26d9.xFaQPd7ooglgopMoKDJNdxDVU4BBtjnmnytjvYsQGN8.szrZdKmq73gyxNV9d0QBHGeSassum0vTplFS58UmfJqvNPpena_PcCPq9A~7f3f6fea645b98a3db3755dc47bb84ee
Upcoming events on Novus Therapeutics, Inc.
Past events on Novus Therapeutics, Inc.
| 09/05/2024 12:30 | Q1 2024 Earnings Release |
| 17/04/2024 18:00 | Noble Capital Markets Emerging Growth Virtual Healthcare Equity Conference |
| 28/03/2024 20:01 | Q4 2023 Earnings Release |
| 04/12/2023 22:00 | Noble Capital Markets Emerging Growth Equity Conference |
| 04/12/2023 17:00 | Noble Capital Markets Emerging Growth Equity Conference |
| 16/11/2023 08:00 | Jefferies London Healthcare Conference |
| 09/11/2023 21:01 | Q3 2023 Earnings Release |
| 02/11/2023 14:00 | American Society of Nephrology Kidney Conference - Poster No - TH-PO835 |
| 27/09/2023 13:00 | Cantor Global Healthcare Conference - Panel |
| 10/08/2023 12:00 | Q2 2023 Earnings Release |
| 21/06/2023 19:30 | Annual General Meeting |
| 09/06/2023 14:00 | Jefferies Global Healthcare Conference |
| 11/05/2023 21:30 | Q1 2023 Earnings Call |
| 11/05/2023 21:01 | Q1 2023 Earnings Release |
| 01/04/2023 10:00 | International Society of Nephrology World Congress - Poster No - SAT-188 |
| 31/03/2023 10:00 | International Society of Nephrology World Congress - Poster No - FRI-316 |
| 30/03/2023 21:30 | Q4 2022 Earnings Call |
| 30/03/2023 21:01 | Q4 2022 Earnings Release |
| 15/02/2023 22:00 | SVB Securities Global Biopharma Conference |
| 14/11/2022 21:30 | Q3 2022 Earnings Call |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
|
EBITDA Million USD | Released Forecast Spread | -12,9 -13,9 7.1% | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
|
EBIT Million USD | Released Forecast Spread | -14,2 -15,3 7.29% | -18,5 -15,5 -19.26% | -36,9 -38,9 5.21% | -88,4 -41,4 -113.75% | -43,0 -44,9 4.28% | -49,0 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -16,0 -15,3 -4.65% | -23,2 -20,6 -12.51% | -36,9 -38,9 5.14% | -88,0 -41,3 -113.17% | -40,3 -42,8 5.78% | -48,0 |
|
Net income Million USD | Released Forecast Spread | -16,0 -15,3 -4.65% | -22,8 -20,5 -11.11% | -34,5 -39,0 11.49% | -88,0 -40,9 -115.02% | -40,3 -42,8 5.67% | -47,8 |
|
EPS USD | Released Forecast Spread | -24,5 -23,9 -2.26% | -15,7 -12,3 -27.75% | -2,33 -2,58 9.62% | -6,16 -2,75 -123.8% | -1,64 -1,77 7.43% | -1,13 |
| Announcement Date | 17/03/20 | 30/03/21 | 24/03/22 | 30/03/23 | 28/03/24 | - |
Quarterly results
| Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
|
EBIT Million USD | Released Forecast Spread | -9,39 -11,6 18.86% | -9,86 -11,2 11.84% | -9,28 -11,3 17.99% | -10,6 -10,9 2.7% | -58,7 -11,5 -410.33% | -11,1 -11,0 -1% | -10,4 -11,4 9.05% | -11,2 -13,6 17.66% | -10,3 -12,2 15.03% | -13,0 | -13,0 | -13,8 | -14,3 | -16,5 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -9,39 -11,5 18.63% | -9,86 -11,2 11.53% | -9,25 -11,3 18.18% | -10,5 -10,9 3.71% | -58,4 -11,5 -408.79% | -10,8 -11,0 1.85% | -9,58 -11,4 15.73% | -10,3 -45,9 77.46% | -9,63 -12,0 19.78% | -13,0 | -12,9 | -13,7 | -14,2 | -16,2 |
|
Net income Million USD | Released Forecast Spread | -8,81 -12,1 27.07% | -9,86 -10,9 9.19% | -9,25 -11,1 16.7% | -10,5 -10,6 1.28% | -58,4 -11,2 -420.51% | -10,8 -10,7 -0.52% | -9,58 -11,4 15.61% | -10,3 -13,0 20.45% | -9,63 -12,0 19.62% | -13,0 | -12,5 | -13,5 | -13,9 | -16,2 |
|
EPS USD | Released Forecast Spread | -0,60 -0,75 20% | -0,69 -0,68 -1.85% | -0,65 -0,70 7.67% | -0,73 -0,68 -7.35% | -4,09 -0,70 -482.21% | -0,75 -0,64 -17.8% | -0,40 -0,46 12.66% | -0,35 -0,46 23.91% | -0,29 -0,39 26.27% | -0,33 | -0,29 | -0,30 | -0,31 | -0,37 |
| Announcement Date | 24/03/22 | 12/05/22 | 11/08/22 | 14/11/22 | 30/03/23 | 11/05/23 | 10/08/23 | 09/11/23 | 28/03/24 | - | - | - | - | - |
More events
Past sector events for Novus Therapeutics, Inc.
| 10/05/2024 21:02 | CASSAVA SCIENCES, INC.: Q1 2024 Earnings Release |
| 10/05/2024 13:26 | ITEOS THERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 10/05/2024 13:00 | PRIME MEDICINE, INC.: Q1 2024 Earnings Release |
| 10/05/2024 12:00 | AKERO THERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 10/05/2024 01:05 | SOLENO THERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 09/05/2024 | TAIMED BIOLOGICS INC.: Q1 2024 Earnings Release (Projected) |
| 09/05/2024 21:15 | ANAPTYSBIO, INC.: Q1 2024 Earnings Release |
| 09/05/2024 21:10 | ASTRIA THERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 09/05/2024 21:09 | XENCOR, INC.: Q1 2024 Earnings Release |
| 09/05/2024 21:05 | STRUCTURE THERAPEUTICS INC.: Q1 2024 Earnings Release |
